Improving enrollment in clinical trials for blood cancers
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
['FUNDING_OTHER'] · JOHNS HOPKINS UNIVERSITY · NIH-10931341
This study is working to make it easier for people with blood cancers to join clinical trials, especially during COVID-19, by creating helpful tools and offering more local options for participation.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | JOHNS HOPKINS UNIVERSITY (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10931341 on ClinicalTrials.gov |
What this research studies
This research aims to enhance the enrollment of patients in clinical trials focused on hematologic malignancies, particularly in the context of challenges posed by COVID-19. It employs a two-pronged approach that addresses both systemic and patient-related barriers to participation. A clinical trial toolkit will be developed to streamline operations, improve trial feasibility, and prioritize studies that best serve patient needs. Additionally, the research seeks to extend clinical trial opportunities to satellite sites, making participation more accessible for patients who prefer local care.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with hematologic malignancies who are seeking treatment options and may benefit from participation in clinical trials.
Not a fit: Patients with non-hematologic cancers or those not interested in clinical trial participation may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased participation in clinical trials, providing patients with access to innovative treatments and improving outcomes in blood cancer care.
How similar studies have performed: Previous research has shown that addressing barriers to clinical trial enrollment can significantly improve participation rates, indicating that this approach has potential for success.
Where this research is happening
BALTIMORE, UNITED STATES
- JOHNS HOPKINS UNIVERSITY — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WAGNER-JOHNSTON, NINA DELANEY — JOHNS HOPKINS UNIVERSITY
- Study coordinator: WAGNER-JOHNSTON, NINA DELANEY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Center